
A dynamic market: Trends transforming the future of obesity drug development
As obesity levels continue to rise, impacting millions globally, the quest for effective treatments has become a critical public health focus. The latest advances in drug development, particularly with glucagon-like peptide-1 (GLP-1) receptor agonists, are …